Insider · CIK 0001162060

SCHNELL DAVID

Reports to the SEC for 9 companies · PALO ALTO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001162060

Forms 4 and 5

Insider transactions

31 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2020-05-20	NGM BIOPHARMACEUTICALS INCStock Option (Right to Buy)A Award	Director	AAward	+16.8K sh	—	—	16,806
2019-05-15	NGM BIOPHARMACEUTICALS INCStock Option (Right to Buy)A Award	Director	AAward	+24K sh	—	—	24,000
2019-04-08	NGM BIOPHARMACEUTICALS INCC Conversion	Director	CConversion	+4.93M sh	—	—	4,925,000
2019-04-08	NGM BIOPHARMACEUTICALS INCSeries A Preferred StockC Conversion	Director	CConversion	−3M sh	—	—	0
2019-04-08	NGM BIOPHARMACEUTICALS INCSeries B Preferred StockC Conversion	Director	CConversion	−1.3M sh	—	—	0
2019-04-08	NGM BIOPHARMACEUTICALS INCSeries C Preferred StockC Conversion	Director	CConversion	−525K sh	—	—	0
2019-04-08	NGM BIOPHARMACEUTICALS INCSeries D Preferred StockC Conversion	Director	CConversion	−100K sh	—	—	0
2013-06-04	KYTHERA BIOPHARMACEUTICALS INCStock Option (right to buy)A Award	Director	AAward	+6,618 sh	—	—	6,618
2012-10-16	KYTHERA BIOPHARMACEUTICALS INCC Conversion	Director	CConversion	+1,476 sh	—	—	1,476
2012-10-16	KYTHERA BIOPHARMACEUTICALS INCC Conversion	Director	CConversion	+1.33M sh	—	—	1,326,627
2012-10-16	KYTHERA BIOPHARMACEUTICALS INCC Conversion	Director	CConversion	+470K sh	—	—	1,796,553
2012-10-16	KYTHERA BIOPHARMACEUTICALS INCC Conversion	Director	CConversion	+118K sh	—	—	1,914,566
2012-10-16	KYTHERA BIOPHARMACEUTICALS INCSeries A Preferred StockC Conversion	Director	CConversion	−1,476 sh	—	—	0
2012-10-16	KYTHERA BIOPHARMACEUTICALS INCSeries B Preferred StockC Conversion	Director	CConversion	−1.31M sh	—	—	0
2012-10-16	KYTHERA BIOPHARMACEUTICALS INCSeries C Preferred StockC Conversion	Director	CConversion	−470K sh	—	—	0
2012-10-16	KYTHERA BIOPHARMACEUTICALS INCSeries D Preferred StockC Conversion	Director	CConversion	−118K sh	—	—	0
2012-10-10	KYTHERA BIOPHARMACEUTICALS INCStock Option (right to buy)A Award	Director	AAward	+5,672 sh	—	—	5,672
2010-10-28	Trubion Pharmaceuticals, IncD Disposition to Issuer	Director	DDisposition to Issuer	−1.83M sh	—	—	1,829,765
2010-10-28	Trubion Pharmaceuticals, IncD Disposition to Issuer	Director	DDisposition to Issuer	−27.9K sh	—	—	27,866
2010-10-28	Trubion Pharmaceuticals, IncStock option (right to purchase)D Disposition to Issuer	Director	DDisposition to Issuer	−12.5K sh	—	—	0
2010-10-28	Trubion Pharmaceuticals, IncStock option (right to purchase)D Disposition to Issuer	Director	DDisposition to Issuer	−5,000 sh	—	—	0
2010-10-28	Trubion Pharmaceuticals, IncStock option (right to purchase)D Disposition to Issuer	Director	DDisposition to Issuer	−5,000 sh	—	—	0
2010-10-28	Trubion Pharmaceuticals, IncStock option (right to purchase)D Disposition to Issuer	Director	DDisposition to Issuer	−5,000 sh	—	—	0
2010-10-28	Trubion Pharmaceuticals, IncStock option (right to purchase)D Disposition to Issuer	Director	DDisposition to Issuer	−5,000 sh	—	—	0
2009-05-27	Trubion Pharmaceuticals, IncStock option (right to purchase)A Award	Director	AAward	+5,000 sh	—	—	5,000
2007-05-25	Trubion Pharmaceuticals, IncStock Option (right to buy)A Award	Director	AAward	+5,000 sh	—	—	5,000
2005-06-03	SENOMYX INCJ Other	Director	JOther	−200K sh	—	—	1,026,395
2005-06-03	SENOMYX INCJ Other	Director	JOther	+1,000 sh	—	—	5,000
2005-05-25	SENOMYX INCStock Option (Right to Buy)A Award	Director	AAward	+11.4K sh	—	—	11,440
2005-05-16	SENOMYX INCJ Other	Director	JOther	−300K sh	—	—	1,226,395
2005-05-16	SENOMYX INCJ Other	Director	JOther	+1,500 sh	—	—	4,000

Recent filings

Accepted (ET)
May 224
SCHNELL DAVID0001209191-20-031868
SEC(opens sec.gov)
May 174
SCHNELL DAVID0001209191-19-030720
SEC(opens sec.gov)
Apr 104
SCHNELL DAVID0001209191-19-024251
SEC(opens sec.gov)
Jun 64
KYTHERA BIOPHARMACEUTICALS INC0001179110-13-009889
SEC(opens sec.gov)
Nov 24
SCHNELL DAVID0001104659-12-073817
SEC(opens sec.gov)
Oct 164
SCHNELL DAVID0001104659-12-069367
SEC(opens sec.gov)
Oct 284
SCHNELL DAVID0001209191-10-052024
SEC(opens sec.gov)

Companies

Address

C/O PROSPECT VENTURE PARTNERS 435 TASSO STREET, SUITE 200

PALO ALTO, CA, 94301